An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery.
about
Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cellsIs there a role for probiotics in the prevention of preterm birth?Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiologyProteomic analysis of amniotic fluid to identify women with preterm labor and intra-amniotic inflammation/infection: the use of a novel computational method to analyze mass spectrometric profilingInfluence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections.Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranesThe matrix metalloproteases and endothelin-1 in infection-associated preterm birth.Patients with an asymptomatic short cervix (<or=15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counselingInfection and smoking are associated with decreased plasma concentration of the anti-aging protein, α-klothoIdentification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.Proteomic analysis of midtrimester amniotic fluid to identify novel biomarkers for preterm delivery.Intrauterine infection and prematurity.The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.No correlation between cerebral palsy and cytokines in postnatal blood of preterms.The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth.Immune aspects and myometrial actions of progesterone and CRH in labor.The relationship between the intensity of intra-amniotic inflammation and the presence and severity of acute histologic chorioamnionitis in preterm gestationIntrauterine infection and preterm labor.Presenting Twins Are Exposed to Higher Levels of Inflammatory Mediators than Nonpresenting Twins as Early as the Midtrimester of Pregnancy.The frequency and clinical significance of intra-amniotic inflammation in women with preterm uterine contractility but without cervical change: do the diagnostic criteria for preterm labor need to be changed?Hematologic profile of the fetus with systemic inflammatory response syndromeThe clinical significance of a positive Amnisure test in women with preterm labor and intact membranesA proposed bio-panel to predict risk for spontaneous preterm birth among African American women.Evidence of perturbations of the cytokine network in preterm laborMidtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm deliverCerebral palsy and fetal inflammatory response syndrome: a review.Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome.Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significanceDysregulation of maternal serum adiponectin in preterm laborFragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammationMidtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes.The frequency and clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell countsIdentification and quantification of preterm birth biomarkers in human cervicovaginal fluid by liquid chromatography/tandem mass spectrometry.Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis.Anti-inflammatory mediators as physiological and pharmacological regulators of parturition.Infection and antibiotics in the aetiology, prediction and prevention of preterm birth.Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation.Early- or mid-trimester amniocentesis biomarkers for predicting preterm delivery: a meta-analysis.Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile.
P2860
Q24294571-356533B3-7669-482F-B8AD-EE054D109A82Q26825756-73FA2782-CF90-441D-B457-91E940DC3E6DQ28385206-F7209C48-B2FD-4C3C-AEC3-035551067DAEQ30484179-68AF4218-7950-4B2B-957A-657F31C5C6AFQ31125863-ECD93946-A1A4-4FE5-B570-3D17A8E6AABAQ34011041-C9FC6E32-1805-4158-B1A1-EABA80503839Q34035600-9E348F75-9217-455F-AB3C-B5EC0E8EFD74Q34080320-8B5658FF-8831-436E-9FA9-FD2D715A0F86Q34088174-6BF495E3-988C-44F1-80EE-8170E6D595FEQ34114194-9B38528E-4DFA-430A-AE83-2D66B0A4926DQ34349870-67F31BE9-F304-4392-8C89-6C46FE6702CDQ34580869-2AF945A9-42C0-49BD-8C0B-5B69BC03F136Q34985972-E69B8123-4BF7-443B-A9B5-38FBC208865AQ35075552-36FD5CC9-B84E-4BCF-B2A3-FB686A9FBECFQ35332660-7D13AEC2-119E-4E01-98C6-60D929F226F5Q35418755-4D159168-8370-42DC-82BC-58D8B804FC27Q35498534-34D690E8-1150-4FA1-B887-2A60F7DE3B2BQ35624100-7B8D3832-6C98-4490-B115-AC2E59D937D7Q35663950-FF070F2A-44F3-413E-8C4A-7CA248FA5B10Q35785239-DFFF5080-296B-4757-BC2A-4C968596B472Q36050821-B5813149-CE6B-4EC5-BAD3-4591A141A2A4Q36173859-DBA19056-15C3-4897-BC64-CB0F0B6CFCE0Q36322601-19A0F59E-D5A4-4061-87E9-78C3A0EA98A5Q36372845-59AB5034-CD69-4B48-8E1A-870B287F354BQ36399892-404035E0-6E69-461C-9F8E-EBD2C1FE7EEEQ36401606-2DAC9BE7-C6B0-4EA9-8BC1-D7E4666F849CQ36487783-B2415FD6-E8CD-4B3C-AF53-FF35102EBF9EQ36604066-30FC71E5-470E-49A9-AB36-F31D2946678AQ36640880-24100F9C-5CDA-4523-8E84-5B48FE8CB387Q36692476-FDACD8C3-27DB-4217-95DF-52D5FB540C2AQ36720470-E5ECA800-9145-4086-BC50-4F320242BA62Q37040946-F88E1AFD-7A5C-41C2-9626-BE08846C1B4BQ37199966-38780950-7ECF-4712-BDB7-30F2485BC23FQ37311954-8599BD36-2B91-4429-B213-4BF8FFDC9576Q37852802-86DDDAB4-F54C-426A-99F2-772C3A015DACQ37927081-5C0F2462-02FD-48C6-B9D7-A15E72201D1EQ38161980-5861D5A6-E594-43ED-B2B8-17384E55DE15Q38520566-B6253098-6521-41D6-8E37-4F3D58A911F5Q39520561-912A9257-93FB-42B4-9785-F064FDBA57CEQ40140125-EBE7853E-BE90-4BC7-8E30-1AE02711E996
P2860
An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@en
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@nl
type
label
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@en
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@nl
prefLabel
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@en
An elevated amniotic fluid mat ...... spontaneous preterm delivery.
@nl
P2093
P356
P1476
An elevated amniotic fluid mat ...... r spontaneous preterm delivery
@en
P2093
P304
P356
10.1067/MOB.2001.117678
P407
P577
2001-11-01T00:00:00Z